Search results for " patients"
Article
Updating Viral Clearance for New Biologic Modalities
Viral clearance processes and guidance must evolve along with newer biotherapeutic modalities.
By Feliza Mirasol
Ensuring viral clearance (i.e., removal) in downstream purification has becom…
Article
Virus-like Particles as Therapeutic Moieties of the Future
Vaccine development
Traditional viral vaccines, which are based on inactivated or attenuated infectious virus, are difficult to produce and may cause adverse reactions in immunocompromised patient…
Article
Reimagining Affordable Biosimilars
Given this arduous journey from lab to market, it is no surprise that biologics demand significant investments, the burden of which ultimately falls on the patients.
Making biotherapeutics af…
Article
Meeting the Process Development Challenges of a Diverse Biologic Pipeline
Click here to read more >>
Understanding the challenges novel and diverse biological molecules can create and how to manage these challenges is key to ensuring they reach patients safely and eff…
Article
Preparing for the Future Visions and Insights for Biomanufacturing
Click here to learn more >>
The biopharmaceutical industry has a reputation of being averse to change. Yet, new market dynamics, such as growing competition from biosimilars and niche drugs targe…
Article
Strategizing for Rapid Changeovers in Biologics Manufacturing
…apabilities to continuously pave the way for innovation and development of life-saving medicines for patients,” he says.
Article
Technology Innovations Improve Process Chromatography Performance
He adds that variability in raw materials can present serious issues that impact downstream efficiency and can lead to long investigations and potential delays in making drugs available for patients. …
Article
Next Generation Process Chromatography
Chromatography is an essential part in the production of all biopharmaceuticals. Without it the industry would not be able to produce therapeutics in an economic manner. This is true for monoclonal …
Article
Good Manufacturing Practices: Challenges with Compliance
WrightStudio/Stock.Adobe.com
The complexity of biologics and the use of new technologies present challenges for complying with CGMPs.
By Lauren Lavelle
…
Article
The Future of Biopharma
…—or even cure diseases completely—as well as ways to address and make these drugs affordable for patients and governments around the world.
When it comes to meeting unmet needs, biosimilars hav…